Colinz Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
72.22
-3.8 (-5.0%)
BSENSE

Feb 03

BSE+NSE Vol: 1.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 621096,
    "name": "Colinz Labs",
    "stock_name": "Colinz Labs",
    "full_name": "Colinz Laboratories Ltd",
    "name_url": "stocks-analysis/colinz-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "72.22",
    "chg": -3.8,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "76.02",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531210,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE923C01011",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.18 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/colinz-labs-621096-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Colinz Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-colinz-labs-fallingrising-3729712",
        "imagepath": "",
        "date": "2025-11-26 00:46:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Colinz Laboratories opened the trading session with a gap down of 5.93%, signalling immediate selling pressure from the outset. Despite an intraday high of ₹43.39, representing a modest 3.26% gain from the previous close, the stock ultimately succumbed to bearish momentum, touching a low of ₹39.53 before settling near that level. The weighted average price indicates that a greater volume of shares exchanged hands closer to the day's low, underscoring the dominance of sellers throughout the session.</p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 7.11% in that span. This short-term weakness is compounded by the fact that Colinz Laboratories has underperformed its sector by 5.2%..."
      },
      {
        "title": "Why is Colinz Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-colinz-labs-fallingrising-3702316",
        "imagepath": "",
        "date": "2025-11-14 21:44:17",
        "description": "As of 14-Nov, Colinz Laboratories Ltd is experiencing a price increase, currently at 42.74, which reflects a rise of 0.94 or 2.25%. The stock has shown strong performance recently, gaining for four consecutive days and achieving a total return of 7.49% during this period. Additionally, it has outperformed its sector by 1.88%. In terms of returns compared to the benchmark, over the past week, the stock has increased by 2.91%, while the Sensex has risen by 1.62%. The stock's delivery volume has also seen a significant increase of 48.13% compared to the five-day average, indicating rising investor participation. However, it is important to note that there is no information available regarding any positive or negative factors that could further explain the stock's recent movement.\n\nBroader Market Context: In the short term, Colinz Laboratories Ltd has outperformed the Sensex, which suggests that investor sentim..."
      },
      {
        "title": "Colinz Laboratories Hits New 52-Week Low at Rs. 36.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-hits-new-52-week-low-at-rs-3611-3696966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ColinzLaborator_priceRelatedfactors_3696966.png",
        "date": "2025-11-13 09:58:38",
        "description": "Colinz Laboratories has reached a new 52-week low of Rs. 36.11, reflecting a year-to-date decline of 32.98%. Despite recent gains over three days, the company faces challenges such as weak long-term fundamentals and low return on equity, while the broader market shows mixed performance."
      },
      {
        "title": "Colinz Laboratories Hits New 52-Week Low at Rs. 37.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-hits-new-52-week-low-at-rs-374-3689984",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ColinzLaborator_priceRelatedfactors_3689984.png",
        "date": "2025-11-11 14:13:49",
        "description": "Colinz Laboratories has reached a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced a notable decline over the past year, with weak financial metrics contributing to its challenges in the market."
      },
      {
        "title": "Why is Colinz Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-colinz-labs-fallingrising-3676571",
        "imagepath": "",
        "date": "2025-11-06 21:25:46",
        "description": "As of 06-Nov, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 39.81, which represents a decrease of 4.42 or 9.99%. The stock has underperformed its sector by 9.22% today and has opened with a loss of 4.07%. It has touched an intraday low of Rs 39.81, indicating significant selling pressure. The stock has also fallen after two consecutive days of gains, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 77.12% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Colinz Laboratories Ltd's performance over the past week shows a decline of 9.48%, while the benchmark Sensex has only decrea..."
      },
      {
        "title": "Colinz Laboratories Ltd Faces 9.99% Decline Amid Significant Selling Pressure and Ongoing Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-faces-999-decline-amid-significant-selling-pressure-and-ongoing-losses-3675987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ColinzLaborator_only_sellers_3675987.png",
        "date": "2025-11-06 14:35:28",
        "description": "Colinz Laboratories Ltd is experiencing substantial selling pressure, with its stock declining significantly over various time frames. The company has faced consecutive losses, underperforming against the Sensex and its sector. Factors contributing to this trend include trading below key moving averages and ongoing challenges in its market position."
      }
    ],
    "total": 590,
    "sid": "621096",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/colinz-laboratories-621096"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Jan-2026",
      "details": "Dear Sir As required under Regulation 47(3) of SEBI (LODR) Regulations 2015. Please find the attached News Paper Publication made towards our issued Quarterly Results for Dec-25. Kindly take the same on records. For Colinz Labs Ltd Director",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "24-Jan-2026",
      "details": "We would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 24th January 2026 has inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the Quarter and Nine Months Ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "24-Jan-2026",
      "details": "As required under Regulations 30 and 33 we are attaching herewith the our Quarterly Results as on Dec-2025. Kindly take the same on records. Directors",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

28-Jan-2026 | Source : BSE

Dear Sir As required under Regulation 47(3) of SEBI (LODR) Regulations 2015. Please find the attached News Paper Publication made towards our issued Quarterly Results for Dec-25. Kindly take the same on records. For Colinz Labs Ltd Director

Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

24-Jan-2026 | Source : BSE

We would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 24th January 2026 has inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the Quarter and Nine Months Ended on 31st December 2025.

Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

24-Jan-2026 | Source : BSE

As required under Regulations 30 and 33 we are attaching herewith the our Quarterly Results as on Dec-2025. Kindly take the same on records. Directors

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available